首页> 美国卫生研究院文献>Annals of Thoracic and Cardiovascular Surgery >Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience
【2h】

Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience

机译:对于恶性胸膜间皮瘤患者胸膜切除术/剥脱术是否优于胸膜外肺切除术?单一机构的经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose: This study was performed to compare the outcome of pleurectomy/decortication (P/D) with that of extrapleural pneumonectomy (EPP) for patients with malignant pleural mesothelioma (MPM).Methods: Patients with MPM underwent either P/D or EPP from August 2008 to December 2014. Various clinicopathological factors were analyzed to identify differences between the two procedures.Results: P/D was performed in nine patients and EPP in 30 patients. Most of the patients’ background characteristics were not significantly different between the groups. The surgery time (680 vs. 586 min, p = 0.0034) and bleeding volume (4050 vs. 2110 mL, p = 0.002) were significantly greater in P/D than in EPP; however, grade ≥3 complications (44% vs. 33%, p = 0.54) and length of postoperative hospital stay (29 vs. 37 days, p = 0.26) were not significantly different. The median survival time and 2- and 3-year survival rates in all patients were 16.7 months, 28.5%, and 15.3%, respectively. The median survival time and 2- and 3-year survival in the P/D and EPP groups were 22.5 months, 43.8%, and 43.8% and 16.5 months, 24.0%, and 14.4%, respectively (p = 0.13).Conclusion: Survival of patients with MPM remains poor despite multidisciplinary treatment. P/D is comparable with EPP and could be a safe and another surgical treatment for patients with MPM.
机译:目的:本研究旨在比较恶性胸膜间皮瘤(MPM)患者的胸膜切除/剥脱术(P / D)与胸膜外肺切除术(EPP)的结果。方法:MPM患者接受了P / D或EPP从2008年8月至2014年12月,分析了各种临床病理因素,以确定两种手术之间的差异。结果:9例患者进行了P / D检查,30例患者进行了EPP检查。两组之间大多数患者的背景特征没有显着差异。与EPP相比,P / D的手术时间(680 vs. 586 min,p = 0.0034)和出血量(4050 vs. 2110 mL,p = 0.002)明显更长;但是,≥3级并发症(44%vs. 33%,p = 0.54)和术后住院时间(29 vs. 37天,p = 0.26)没有显着差异。所有患者的中位生存时间和2年和3年生存率分别为16.7个月,28.5%和15.3%。 P / D和EPP组的中位生存时间以及2年和3年生存率分别为22.5个月,43.8%和43.8%和16.5个月,24.0%和14.4%(p = 0.13)。尽管进行了多学科治疗,但MPM患者的生存仍然很差。 P / D可与EPP相提并论,对于MPM患者而言,P / D可能是一种安全的手术疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号